MSF Scientific Days

9-10 May 2019
London, UK

  • Fabiana Barreira, Chagas Senior Clinical Manager – presentation of the BENDITA trial for Chagas disease
  • Nathalie Strub-Wourgaft, Director NTDs – presentation on registration steps for the new all oral sleeping sickness treatment

R&D Portfolio Update February 2019: DNDi Sleeping sickness programme

Fexinidazole, the first all-oral treatment for both stages of HAT caused by T.b gambiense and DNDi’s first new chemical entity, was recommended by the European Medicines Agency in November and registered in Democratic Republic of Congo (DRC) in December 2018. The Phase II/III study on acoziborole opened new clinical sites in DRC and Guinea.

ISNTD Festival 2019

11-12 March 2019
London, United Kingdom

  • Submission of the film “A doctor’s dream” to the ISNTD Festival Awards

Agence Congolaise de Presse [31 January 2019]

“La RDC célèbre mercredi le premier anniversaire de la journée nationale le de la Trypanosomiase humaine africaine (THA)” – “DRC celebrates the first anniversary of National Human Trypanosomiasis (HAT) Day on Wednesday”